This is a condition where too much fat builds up in your liver. It's like the liver is getting 'fatty'. This can happen for many reasons, including things you eat or drink, or other health problems. It's often not serious, but it can sometimes lead to more serious liver issues if not managed.
Every report comes from a Lived member, sent anonymously.
Have you tried Zepbound / Mounjaro (Tirzepatide) for Fatty Liver?
Fatty liver, also called hepatic steatosis, means that too much fat has built up inside the cells of the liver. A small amount of fat in the liver is normal; the concern begins when it accumulates beyond that. Doctors now often use the broader term steatotic liver disease and sort it by cause. The most common type is metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called nonalcoholic fatty liver disease or NAFLD), which is linked to excess weight, type 2 diabetes and related conditions. The other main type is alcohol-associated liver disease, caused by heavy drinking. Some people have features of both. What matters most is whether the fat is causing damage. Many people have simple fatty liver, with little or no inflammation, and it usually does not go on to harm the liver. In a smaller group, the fat comes with inflammation and injury to liver cells, called steatohepatitis (MASH in the metabolic form). Over years, this can cause fibrosis, or scarring, which can progress to cirrhosis and raise the risk of liver cancer. Fatty liver usually causes few or no symptoms, even when scarring is present, so it is most often found by chance on a blood test or scan. When symptoms do occur, they tend to be tiredness or a vague discomfort in the upper right side of the belly.
In MASLD, fat collects in the liver as part of a wider change in how the body handles sugar and fat. It is closely tied to obesity, especially weight carried around the waist, insulin resistance and type 2 diabetes, high triglycerides or low HDL (good) cholesterol, and high blood pressure. The current definition requires at least one of these cardiometabolic risk factors. Type 2 diabetes stands out because it raises the chance of scarring, not just of fat. Risk also rises with age, and genes help explain why the condition runs in some families and is more common in some ethnic groups, including Hispanic people. Children can develop it too. Alcohol is a cause in its own right. Heavy drinking over a long period can produce fatty liver by itself, and in someone with metabolic risk factors, even moderate drinking increases the chance of advanced scarring. Less often, fat builds up for other reasons: certain medicines (such as corticosteroids, some HIV and cancer treatments, and estrogens), rapid weight loss or malnutrition, hepatitis C, some toxins, and rare inherited conditions such as Wilson disease. These factors raise the likelihood of fatty liver without determining it, and having one is not a judgment about a person's habits.
Fatty liver is often first suspected when a routine blood test shows raised liver enzymes, called ALT (alanine aminotransferase) and AST (aspartate aminotransferase), or when an ultrasound or CT scan done for another reason shows fat in the liver. A clinician will ask in detail about alcohol, medicines and supplements, check weight and blood pressure, and test for other liver diseases such as viral hepatitis, because the cause shapes treatment. Finding fat is only the first step. The more important question is how much scarring is present. A common first check is the FIB-4 (fibrosis-4) score, calculated from age, ALT, AST and platelet count. A low score makes advanced scarring unlikely. A higher or borderline score usually leads to elastography, a test that measures how stiff the liver is, since scarred tissue is stiffer. The most widely used version, often known by the brand FibroScan, is an ultrasound-based scan done in a clinic; magnetic resonance elastography is a more detailed MRI option. Standard ultrasound and CT can show fat but cannot show inflammation or scarring. A liver biopsy, in which a small sample of tissue is removed with a needle, is the only test that can confirm steatohepatitis and show exactly how much scarring there is. Most people do not need one. It is usually reserved for situations where noninvasive tests are unclear, point to advanced disease, or another liver condition needs to be ruled out.
For most people with MASLD, treatment centers on gradual, sustained changes in eating and activity. Losing about 3 to 5 percent of body weight reduces liver fat; losing around 10 percent or more is generally needed to calm inflammation and improve scarring. Weight should come off steadily, because very rapid loss or malnutrition can make liver disease worse. Regular exercise helps the liver and the heart even when weight does not change. No single diet has proved clearly best. A Mediterranean-style pattern and cutting back on sugary drinks, refined carbohydrates and saturated fat are common starting points, and a dietitian can help make changes last. Alcohol makes every form of fatty liver worse. For alcohol-associated disease, stopping drinking is the most important treatment, and counseling, recovery programs and medicines that reduce cravings can help. People with MASLD should avoid heavy drinking and ask their clinician whether any amount is safe for them. For adults whose tests show MASH with moderate to advanced scarring but not cirrhosis, two medicines are FDA-approved for use alongside diet and exercise. Resmetirom (Rezdiffra) is a once-daily tablet that activates a type of thyroid hormone receptor; its most common side effects include diarrhea and nausea. Semaglutide (Wegovy), a once-weekly injection from the GLP-1 (glucagon-like peptide-1) receptor agonist family that is also used for weight loss, is approved for the same group. Both were approved because they improved liver inflammation and scarring in clinical trials, and studies are still confirming whether that leads to fewer cases of cirrhosis and liver failure. Neither is approved for simple fatty liver. Treating related conditions is part of treating the liver. Some diabetes medicines, such as pioglitazone, can improve steatohepatitis as well as blood sugar. Statins for cholesterol are safe in fatty liver, including advanced disease. Bariatric (weight-loss) surgery can resolve steatohepatitis and improve scarring in people with obesity who qualify for it. Vitamin E has improved steatohepatitis in some trials, but long-term high doses carry possible risks, including bleeding, that are worth discussing first. Check with a clinician before trying other supplements or herbal remedies, since some can damage the liver.
Fatty liver is usually a long-term condition, but it is not fixed. Liver fat responds to weight change, and steatohepatitis can settle with sustained weight loss and return if weight is regained. Most people with simple fatty liver never develop serious liver problems. In people with steatohepatitis, scarring usually advances slowly, over many years, and the amount of scarring is the best guide to future liver risk. Scarring that has not reached cirrhosis can improve when the underlying causes are treated. For many people, the larger long-term threat is to the heart rather than the liver. Heart and blood vessel disease is the most common cause of death in people with MASLD, so keeping blood pressure, cholesterol and blood sugar under control matters as much as the liver results. Fatty liver also raises the chance of developing type 2 diabetes. For most people, follow-up is fairly quiet: periodic blood tests and, depending on risk, repeat FIB-4 scores or elastography to see whether scarring is changing. People found to have cirrhosis need closer care, including liver cancer screening twice a year and checks for complications. Vaccination against hepatitis A and B is often recommended to protect a liver that is already under strain.
Ask about a liver assessment if a blood test shows raised liver enzymes or a scan mentions fat in the liver, or if you have type 2 diabetes, obesity with other metabolic problems, a history of heavy drinking, or a parent or sibling with cirrhosis. These groups are advised to be checked for scarring even without symptoms. Contact your care team if you notice persistent itching, easy bruising, swelling in the legs or ankles, loss of appetite or unexplained weight loss, since these can be early signs that the liver is becoming scarred. Vomiting blood, bleeding from the rectum, new confusion or unusual drowsiness, or yellowing of the skin or eyes or swelling of the belly that appears or worsens quickly need emergency care, particularly in someone already known to have cirrhosis.
Last reviewed • Oct 2026
Educational content, not medical advice.
With Fatty Liver disease it’s important to diet and exercise I’m finding I’m losing the motivation to stay on task. Looking to get that motivation back to keep pushing forward
Was just recently diagnosed with fatty liver. Doctors always tell me to lose weight. I lose some, doctors congratulate me but it seems the results never change. Feels like it’s all for nothing.